Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Thromb Haemost. 2013 May 16;110(1):53–61. doi: 10.1160/TH13-03-0184

Figure 7.

Figure 7

Plasma clotting activities of recombinant FX-WT and FX-Thr211Pro. The clotting activities of FX-WT (○) FX-Thr211Pro (●) were determined using FX-deficient plasma by both PT (panel A) and aPTT (panel B) assays as a function of different concentrations of the zymogens at 37 °C as described under “Materials and methods”. Data are derived from three independent measurements (±SD).